The Patent Finder

Universidad de Chile

Also on record
Records under this name other than the patents Universidad de Chile holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.

Back to Universidad de Chile

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,618,904Promoter with an Enriched Cytosine-Guanine Dinucleotide Region, Vectors, Cellular Lines, Method for Producing Recombinant Protein
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,400,166AAV/XBP1S-HA Virus, Gene Therapy Method and Use Thereof in the Optimisation and Improvement of Learning, Memory and Cognitive Capacities
Lapsed on the fee record
Ended Aug 2, 2026 · High confidence
Lapsed on the fee recordEnded Aug 2, 2026High confidence
US 11,261,472Peptide Sequence of a Guide Protein for the Production of a Peptide of Interest, an Expression Vector, a Host Cell, and a Method for the Production of a Peptide of Interest
Lapsed on the fee record
Ended Mar 1, 2026 · High confidence
Lapsed on the fee recordEnded Mar 1, 2026High confidence
US 11,181,523Method for the early detection of acute kidney injury in critical patients, using fibroblast growth factor 23, klotho and erythropoietin as biomarkers
Lapsed on the fee record
Ended Nov 23, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 23, 2025USPTO record
US 9,664,930In situ polymerisation process for obtaining an electro-optical apparatus, said polymer and electro-optical apparatus; and uses thereof
Lapsed on the fee record
Ended May 30, 2025 · USPTO record
Lapsed on the fee recordEnded May 30, 2025USPTO record
US 9,511,120Use of the angiotensin-(1-9) peptide or derivatives thereof, use of vectors overexpressing the ACE2 enzyme that produces angiotensin-(1-9) for preparing medicaments useful for preventing, reverting, inhibiting and/or reducing hypertension and/or inducing vasodilation
Lapsed on the fee record
Ended Dec 6, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 6, 2024USPTO record
US 10,683,546Kit for predicting treatment with glucocorticoids and method comprising the same
Lapsed on the fee record
Ended Jun 16, 2024 · USPTO record
Lapsed on the fee recordEnded Jun 16, 2024USPTO record
US 8,198,300Method for preventing tau protein aggregation and treating Alzheimer's disease with a quinoline derivative compound
Lapsed on the fee record
Ended Jun 12, 2024 · USPTO record
Lapsed on the fee recordEnded Jun 12, 2024USPTO record
US 10,634,682Method for visualizing biomolecules, such as proteins or nucleic acids, with the unaided eye, without needing to use potentially toxic compounds, exposure to ultraviolet (UV) light or fluorescence
Lapsed on the fee record
Ended Apr 28, 2024 · USPTO record
Lapsed on the fee recordEnded Apr 28, 2024USPTO record
US 10,548,565Manual, portable ultrasonography device, with centralized control and processing in the hardware and with display outputs, which operates in real time with a high image refresh rate
Lapsed on the fee record
Ended Feb 4, 2024 · USPTO record
Lapsed on the fee recordEnded Feb 4, 2024USPTO record
10 of 26 patents shown.
Pro members see all 26.
Pro members: see all 26 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited